1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
2. Health Promotion Administration, Ministry of Health Welfare. Taiwan Cancer Registry Statistical Service (1980–2017). http://tcr.cph.ntu.edu.tw/main.php?Page=A5B2(Chinese). (2020).
3. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B. & Issa, J. P. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681–8686 (1999).
4. Issa, J. P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988–993 (2004).
5. Weisenberger, D. J., Levine, A. J., Long, T. I., Buchanan, D. D., Walters, R., Clendenning, M. et al. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology 24, 512–519 (2015).